DK1381367T3 - Oral aripiprazolopløsning - Google Patents

Oral aripiprazolopløsning

Info

Publication number: DK1381367T3
Authority: DK; Denmark
Prior art keywords: oral aripiprazole; aripiprazole solution; oral; solution; aripiprazole
Prior art date: 2001-04-25

Application number

DK02723964.9T

Other languages

English (en)

Inventor

Joyce Chou

Prakash Parab

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-25

Filing date

2002-04-24

Publication date

2012-04-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23099862&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1381367(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-24 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2012-04-10 Application granted granted Critical

2012-04-10 Publication of DK1381367T3 publication Critical patent/DK1381367T3/da

Links

CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title 1
229960004372 aripiprazole Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Psychiatry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK02723964.9T 2001-04-25 2002-04-24 Oral aripiprazolopløsning DK1381367T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28671801P	2001-04-25	2001-04-25
PCT/US2002/013048 WO2002085366A1 (en)	2001-04-25	2002-04-24	Aripiprazole oral solution

Publications (1)

Publication Number	Publication Date
DK1381367T3 true DK1381367T3 (da)	2012-04-10

Family

ID=23099862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02723964.9T DK1381367T3 (da)	2001-04-25	2002-04-24	Oral aripiprazolopløsning

Country Status (37)

Country	Link
US (1)	US6977257B2 (da)
EP (2)	EP1381367B1 (da)
JP (1)	JP4401077B2 (da)
KR (1)	KR100909329B1 (da)
CN (1)	CN1512884B (da)
AR (1)	AR033168A1 (da)
AT (1)	ATE537831T1 (da)
AU (1)	AU2002254722B2 (da)
BG (1)	BG66177B1 (da)
BR (1)	BR0208986A (da)
CA (1)	CA2445276C (da)
CY (1)	CY1112606T1 (da)
CZ (1)	CZ306181B6 (da)
DK (1)	DK1381367T3 (da)
EE (1)	EE05581B1 (da)
ES (1)	ES2377855T3 (da)
GE (1)	GEP20053602B (da)
HK (2)	HK1058316A1 (da)
HR (1)	HRP20030870B1 (da)
HU (1)	HU230456B1 (da)
IL (2)	IL158202A0 (da)
IS (1)	IS2863B (da)
MX (1)	MXPA03009728A (da)
MY (1)	MY129350A (da)
NO (1)	NO324606B1 (da)
NZ (1)	NZ528550A (da)
PE (1)	PE20021086A1 (da)
PL (1)	PL206882B1 (da)
PT (1)	PT1381367E (da)
RS (1)	RS52082B (da)
RU (1)	RU2295960C2 (da)
SK (1)	SK287948B6 (da)
TW (1)	TWI337865B (da)
UA (1)	UA76144C2 (da)
UY (1)	UY27273A1 (da)
WO (1)	WO2002085366A1 (da)
ZA (1)	ZA200307797B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6770478B2 (en) *	2000-02-10	2004-08-03	The Regents Of The University Of California	Erythrocytic cells and method for preserving cells
PL212428B1 (pl) *	2002-08-20	2012-09-28	Bristol Myers Squibb Co	Kompleks aripiprazolu, preparat farmaceutyczny zawierajacy ten kompleks i jego zastosowanie
JP4959335B2 (ja) *	2003-10-08	2012-06-20	マリンクロッドエルエルシー	メチルフェニデート溶液および関連する投与および製造方法
JP4836797B2 (ja) *	2003-10-23	2011-12-14	大塚製薬株式会社	放出制御性無菌注射アリピプラゾール製剤および方法
WO2005070390A2 (en) *	2004-01-21	2005-08-04	Janssen Pharmaceutica N.V.	Mitratapide oral solution
US20070148100A1 (en)	2005-09-15	2007-06-28	Elan Pharma International, Limited	Nanoparticulate aripiprazole formulations
CA2627695A1 (en) *	2006-01-05	2007-07-19	Teva Pharmaceutical Industries Ltd.	Dry formulations of aripiprazole
JP4875001B2 (ja) *	2006-01-05	2012-02-15	テバファーマシューティカルインダストリーズリミティド	アリピプラゾールの湿式造粒医薬組成物
JP4892264B2 (ja) *	2006-03-30	2012-03-07	高田製薬株式会社	リスペリドン水性液剤
ATE523602T1 (de)	2006-06-12	2011-09-15	Hadasit Med Res Service	Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen
GB0618879D0 (en)	2006-09-26	2006-11-01	Zysis Ltd	Pharmaceutical compositions
CA2695178C (en)	2007-07-31	2015-06-23	Otsuka Pharmaceutical Co., Ltd.	Methods for producing aripiprazole suspension and freeze-dried formulation
WO2009042166A1 (en) *	2007-09-25	2009-04-02	Panacos Pharmaceuticals, Inc.	Liquid bevirimat dosage forms for oral administration
GB2456183A (en) *	2008-01-04	2009-07-08	Gw Pharma Ltd	Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
SG172363A1 (en)	2008-12-23	2011-07-28	Pharmasset Inc	Synthesis of purine nucleosides
WO2010075517A2 (en)	2008-12-23	2010-07-01	Pharmasset, Inc.	Nucleoside analogs
CN102695513A (zh)	2008-12-23	2012-09-26	吉利德制药有限责任公司	核苷氨基磷酸酯
TWI598358B (zh)	2009-05-20	2017-09-11	基利法瑪席特有限責任公司	核苷磷醯胺
US8815261B2 (en) *	2009-06-19	2014-08-26	Medrx Co., Ltd.	Composition for external application comprising aripiprazole and organic acid as active ingredients
TR201000948A1 (tr)	2010-02-09	2011-08-22	Sanovel İlaç San.Ve Ti̇c.A.Ş.	Aripiprazol formülasyonları.
PL3290428T3 (pl)	2010-03-31	2022-02-07	Gilead Pharmasset Llc	Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
SG184323A1 (en)	2010-03-31	2012-11-29	Gilead Pharmasett Llc	Stereoselective synthesis of phosphorus containing actives
WO2011123672A1 (en)	2010-03-31	2011-10-06	Pharmasset, Inc.	Purine nucleoside phosphoramidate
JP6069215B2 (ja)	2010-11-30	2017-02-01	ギリアドファーマセットエルエルシー	化合物
MX358344B (es)	2011-03-18	2018-08-15	Alkermes Pharma Ireland Ltd	Composiciones farmaceuticas que comprenden un antipsicotico insoluble en agua y esteres de sorbitan.
JO3410B1 (ar) *	2011-06-07	2019-10-20	Otsuka Pharma Co Ltd	تركيبة أريبيبرازول مجفف بالتبريد
CN102846616B (zh) *	2011-06-27	2015-05-06	上海中西制药有限公司	一种阿立哌唑制剂及其制备方法
US9241876B2 (en)	2011-06-27	2016-01-26	Shanghai Zhongxi Pharmaceutical Corporation	Aripiprazole medicament formulation and preparation method therefor
JO3190B1 (ar) *	2011-10-19	2018-03-08	Otsuka Pharma Co Ltd	محلول للتناول عن طريق الفم
AU2013235519C1 (en)	2012-03-19	2018-04-26	Alkermes Pharma Ireland Limited	Pharmaaceutical compositions comprising fatty acid esters
AU2013235526B2 (en)	2012-03-19	2017-11-30	Alkermes Pharma Ireland Limited	Pharmaceutical compositions comprising benzyl alcohol
EP2827867B1 (en)	2012-03-19	2019-11-06	Alkermes Pharma Ireland Limited	Pharmaceutical compositions comprising glycerol esters
JOP20200109A1 (ar)	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن
JP5341282B1 (ja) *	2012-06-29	2013-11-13	丸石製薬株式会社	アリピプラゾールの経口医薬製剤
WO2014002553A1 (ja)	2012-06-29	2014-01-03	丸石製薬株式会社	アリピプラゾールの経口医薬製剤
KR101571670B1 (ko)	2012-08-08	2015-11-25	주식회사 씨엠지제약	아리피프라졸을 포함하는 경구용 속용 필름 제제
NZ631345A (en)	2012-09-19	2017-06-30	Alkermes Pharma Ireland Ltd	Pharmaceutical compositions having improved storage stability
SG10201702048VA (en) *	2012-09-26	2017-04-27	Bristol Myers Squibb Holdings Ireland	Apixaban liquid formulations
US8568747B1 (en)	2012-10-05	2013-10-29	Silvergate Pharmaceuticals, Inc.	Enalapril compositions
WO2014059363A1 (en) *	2012-10-11	2014-04-17	Antrim Pharmaceuticals Llc	Oral solution formulations of aripiprazole
EP2908859B1 (en) *	2012-10-16	2017-05-17	Arven Ilac Sanayi ve Ticaret A.S.	Aripiprazole formulations
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
JP6203682B2 (ja) *	2013-07-10	2017-09-27	共和薬品工業株式会社	アリピプラゾール含有水性液剤
CN103393594A (zh) *	2013-08-22	2013-11-20	万特制药(海南)有限公司	一种新的阿立哌唑的制剂组合物
MX376057B (es)	2014-03-20	2025-03-07	Alkermes Pharma Ireland Ltd	Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion.
WO2016189504A1 (en) *	2015-05-28	2016-12-01	Leiutis Pharmaceuticals Pvt Ltd	Non-lyophilized compositions of aripiprazole and methods of preparation thereof
JP6039849B1 (ja) *	2015-06-12	2016-12-07	高田製薬株式会社	アリピプラゾール含有内用液剤
WO2017025930A1 (en) *	2015-08-12	2017-02-16	Ftf Pharma Private Limited	Oral solution of aripiprazole
US9463183B1 (en)	2015-10-30	2016-10-11	Silvergate Pharmaceuticals, Inc.	Lisinopril formulations
US9669008B1 (en)	2016-03-18	2017-06-06	Silvergate Pharmaceuticals, Inc.	Enalapril formulations
CN108434146A (zh) *	2017-02-16	2018-08-24	天津国际生物医药联合研究院	一种hiv-1整合酶抑制剂的溶液剂及其制备方法和应用
CN109498556A (zh) *	2017-09-15	2019-03-22	万特制药(海南)有限公司	阿立哌唑口服溶液及其制备方法
EP3761983A1 (en)	2018-03-05	2021-01-13	Alkermes Pharma Ireland Limited	Aripiprazole dosing strategy
CN112666267B (zh) *	2019-10-15	2023-09-26	上海上药中西制药有限公司	一种阿立哌唑药品有关物质的检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU843739A3 (ru) †	1978-02-17	1981-06-30	Карл Томэ Гмбх (Фирма)	Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
JPS54130587A (en)	1978-03-30	1979-10-09	Otsuka Pharmaceut Co Ltd	Carbostyryl derivative
PH17194A (en) *	1980-03-06	1984-06-19	Otsuka Pharma Co Ltd	Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5959663A (ja) †	1982-09-29	1984-04-05	Otsuka Pharmaceut Co Ltd	カルボスチリル誘導体−シクロデキストリン包接化合物
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
DE3933027A1 (de) *	1989-09-29	1991-04-11	Schering Ag	Kombinationspraeparat mit antithrombotischer wirkung
JP3265680B2 (ja) *	1992-03-12	2002-03-11	大正製薬株式会社	経口製剤用組成物
US5457099A (en) †	1992-07-02	1995-10-10	Sawai Pharmaceutical Co., Ltd.	Carbostyril derivatives and antiallergic agent
TW254855B (da)	1993-07-28	1995-08-21	Otsuka Pharma Co Ltd
PL335934A1 (en) *	1997-03-31	2000-05-22	Johnson & Johnson Consumer	Solvent system of increased penetration into pharmaceutical compounds
US20030077227A1 (en) *	1997-10-01	2003-04-24	Dugger Harry A.	Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
BR9913432A (pt) *	1998-09-03	2001-10-09	Alcide Corp	Germicidas tópicos resistentes ao congelamento e métodos a eles relacionados
CA2311734C (en) *	2000-04-12	2011-03-08	Bristol-Myers Squibb Company	Flash-melt oral dosage formulation
US20020076437A1 (en) *	2000-04-12	2002-06-20	Sanjeev Kothari	Flashmelt oral dosage formulation

2002
- 2002-03-28 MY MYPI20021124A patent/MY129350A/en unknown
- 2002-04-15 AR ARP020101366A patent/AR033168A1/es unknown
- 2002-04-19 TW TW091108139A patent/TWI337865B/zh not_active IP Right Cessation
- 2002-04-24 PL PL364666A patent/PL206882B1/pl unknown
- 2002-04-24 SK SK1264-2003A patent/SK287948B6/sk not_active IP Right Cessation
- 2002-04-24 HU HU0303946A patent/HU230456B1/hu not_active IP Right Cessation
- 2002-04-24 BR BR0208986-6A patent/BR0208986A/pt active Search and Examination
- 2002-04-24 WO PCT/US2002/013048 patent/WO2002085366A1/en active IP Right Grant
- 2002-04-24 EP EP02723964A patent/EP1381367B1/en not_active Expired - Lifetime
- 2002-04-24 KR KR1020037013943A patent/KR100909329B1/ko not_active Expired - Lifetime
- 2002-04-24 UA UA20031110599A patent/UA76144C2/uk unknown
- 2002-04-24 CZ CZ2003-2821A patent/CZ306181B6/cs not_active IP Right Cessation
- 2002-04-24 MX MXPA03009728A patent/MXPA03009728A/es active IP Right Grant
- 2002-04-24 RU RU2003132426/15A patent/RU2295960C2/ru not_active IP Right Cessation
- 2002-04-24 EP EP11190103.9A patent/EP2436384B2/en not_active Expired - Lifetime
- 2002-04-24 DK DK02723964.9T patent/DK1381367T3/da active
- 2002-04-24 CN CN028112148A patent/CN1512884B/zh not_active Ceased
- 2002-04-24 PT PT02723964T patent/PT1381367E/pt unknown
- 2002-04-24 NZ NZ528550A patent/NZ528550A/en not_active IP Right Cessation
- 2002-04-24 GE GE5332A patent/GEP20053602B/en unknown
- 2002-04-24 UY UY27273A patent/UY27273A1/es not_active Application Discontinuation
- 2002-04-24 ES ES02723964T patent/ES2377855T3/es not_active Expired - Lifetime
- 2002-04-24 AT AT02723964T patent/ATE537831T1/de active
- 2002-04-24 AU AU2002254722A patent/AU2002254722B2/en not_active Expired
- 2002-04-24 JP JP2002582939A patent/JP4401077B2/ja not_active Expired - Lifetime
- 2002-04-24 IL IL15820202A patent/IL158202A0/xx active IP Right Grant
- 2002-04-24 RS YU84703A patent/RS52082B/sr unknown
- 2002-04-24 EE EEP200300523A patent/EE05581B1/xx not_active IP Right Cessation
- 2002-04-24 US US10/131,304 patent/US6977257B2/en not_active Expired - Lifetime
- 2002-04-24 CA CA002445276A patent/CA2445276C/en not_active Expired - Fee Related
- 2002-04-25 PE PE2002000346A patent/PE20021086A1/es not_active Application Discontinuation
2003
- 2003-10-01 BG BG108216A patent/BG66177B1/bg unknown
- 2003-10-01 IL IL158202A patent/IL158202A/en not_active IP Right Cessation
- 2003-10-06 ZA ZA200307797A patent/ZA200307797B/en unknown
- 2003-10-14 IS IS6994A patent/IS2863B/is unknown
- 2003-10-21 NO NO20034705A patent/NO324606B1/no not_active IP Right Cessation
- 2003-10-24 HR HR20030870A patent/HRP20030870B1/xx not_active IP Right Cessation
2004
- 2004-02-19 HK HK04101190.2A patent/HK1058316A1/xx not_active IP Right Cessation
2012
- 2012-03-14 CY CY20121100273T patent/CY1112606T1/el unknown
- 2012-09-28 HK HK12109608.1A patent/HK1168792A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
UY27273A1 (es)	2002-11-29
IL158202A (en)	2008-04-13
UA76144C2 (uk)	2006-07-17
AR033168A1 (es)	2003-12-03
CZ306181B6 (cs)	2016-09-14
EP1381367A4 (en)	2009-07-01
PE20021086A1 (es)	2002-12-14
MXPA03009728A (es)	2004-01-29
US6977257B2 (en)	2005-12-20
US20020193438A1 (en)	2002-12-19
NO20034705D0 (no)	2003-10-21
HK1058316A1 (en)	2004-05-14
KR20030096332A (ko)	2003-12-24
CA2445276A1 (en)	2002-10-31
AU2002254722B2 (en)	2006-11-09
EP1381367B1 (en)	2011-12-21
HK1168792A1 (en)	2013-01-11
IL158202A0 (en)	2004-05-12
BG66177B1 (bg)	2011-11-30
GEP20053602B (en)	2005-08-10
CZ20032821A3 (cs)	2004-09-15
MY129350A (en)	2007-03-30
PL364666A1 (en)	2004-12-13
JP4401077B2 (ja)	2010-01-20
HRP20030870B1 (en)	2011-10-31
WO2002085366A1 (en)	2002-10-31
HU230456B1 (hu)	2016-07-28
PT1381367E (pt)	2012-03-01
RU2295960C2 (ru)	2007-03-27
IS6994A (is)	2003-10-14
CN1512884B (zh)	2010-05-26
KR100909329B1 (ko)	2009-07-24
YU84703A (sh)	2006-08-17
NO20034705L (no)	2003-11-28
HUP0303946A2 (hu)	2004-04-28
ZA200307797B (en)	2004-10-06
EE05581B1 (et)	2012-10-15
BG108216A (bg)	2004-12-30
EP2436384B1 (en)	2015-06-10
TWI337865B (en)	2011-03-01
SK12642003A3 (sk)	2004-07-07
EP2436384A3 (en)	2012-09-19
CN1512884A (zh)	2004-07-14
NO324606B1 (no)	2007-11-26
EP2436384B2 (en)	2018-05-23
NZ528550A (en)	2005-03-24
JP2004532225A (ja)	2004-10-21
EP2436384A2 (en)	2012-04-04
CA2445276C (en)	2009-10-13
CY1112606T1 (el)	2016-02-10
RS52082B (sr)	2012-06-30
BR0208986A (pt)	2004-04-20
HRP20030870A2 (en)	2004-06-30
EP1381367A1 (en)	2004-01-21
ES2377855T3 (es)	2012-04-02
PL206882B1 (pl)	2010-10-29
IS2863B (is)	2013-12-15
RU2003132426A (ru)	2005-04-20
EE200300523A (et)	2004-02-16
ATE537831T1 (de)	2012-01-15
HUP0303946A3 (en)	2005-06-28
SK287948B6 (sk)	2012-06-04

Publication	Publication Date	Title
DK1381367T3 (da)	2012-04-10	Oral aripiprazolopløsning
ATE548938T1 (de)	2012-03-15	Zahnbürste
ATE513491T1 (de)	2011-07-15	Zahnbürste
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
NO20042121D0 (no)	2004-05-24	Kinolinforbindelse
EE200300416A (et)	2003-12-15	Ravimvorm
NO20035315D0 (no)	2003-11-28	Farmasöytiske kombinasjoner
DE60214455D1 (de)	2006-10-19	Dentale Reibahle
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
DE60225985D1 (de)	2008-05-21	Dentaleinheit
DE50203644D1 (de)	2005-08-18	Abseilvorrichtung
DE60210813D1 (de)	2006-05-24	Zahnbürste
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
DE60201822D1 (de)	2004-12-09	Sterilisierverfahren
NO20033586D0 (no)	2003-08-13	Tannbörste
SE0102823D0 (sv)	2001-08-24	New drug
SE0102714D0 (sv)	2001-08-14	Artikulator
SE0103116D0 (sv)	2001-09-17	Pharmaceutical combination
DE60129610D1 (de)	2007-09-06	Inhalationsgerät
NO20015559D0 (no)	2001-11-14	Kreklinggel±
FI5191U1 (fi)	2001-12-28	Hammasharja
FI20012564A0 (fi)	2001-12-21	Hammasharja
FI20010192A0 (fi)	2001-02-01	Uusi äidinmaidonkorvikekoostumus
SE0102054D0 (sv)	2001-06-08	New Combination
SE0102059D0 (sv)	2001-06-08	New combination